Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer
出版年份 2021 全文链接
标题
Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer
作者
关键词
-
出版物
MEDICINE
Volume 100, Issue 18, Pages e25690
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-05-06
DOI
10.1097/md.0000000000025690
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Investigation on Advanced Non-Small-Cell Lung Cancer among Elderly Patients Treated with Chinese Herbal Medicine versus Chemotherapy: A Pooled Analysis of Individual Data
- (2019) Lingling Sun et al. Evidence-based Complementary and Alternative Medicine
- Traditional Chinese medicine treatment as adjuvant therapy in completely resected stage IB-IIIA non-small cell lung cancer: Study protocol for a multi-center, double-blind, randomized, placebo-controlled trial
- (2019) Yi Jiang et al. Clinical Lung Cancer
- Broad range metabolomics coupled with network analysis for explaining possible mechanisms of Er-Zhi-Wan in treating liver-kidney Yin deficiency syndrome of Traditional Chinese medicine
- (2019) Yuanyuan Zhai et al. JOURNAL OF ETHNOPHARMACOLOGY
- A Chinese Prescription Chuanxiong Chatiao San for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2019) Yu Wang et al. Evidence-based Complementary and Alternative Medicine
- Kangai Injection, a Traditional Chinese Medicine, Improves Efficacy and Reduces Toxicity of Chemotherapy in Advanced Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
- (2019) Siqi Huang et al. Evidence-based Complementary and Alternative Medicine
- Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway
- (2019) Song Chian et al. ANTI-CANCER DRUGS
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- The Traditional Chinese Medicine Kangai Injection as an Adjuvant Method in Combination with Chemotherapy for the Treatment of Breast Cancer in Chinese Patients: A Meta-Analysis
- (2018) Jing-Xian Xue et al. Evidence-based Complementary and Alternative Medicine
- Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis
- (2018) Qiang Lu et al. LIFE SCIENCES
- Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway
- (2018) Yanxia Jin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non–Small-Cell Lung Cancer
- (2017) Kenneth E. Rosenzweig et al. JOURNAL OF CLINICAL ONCOLOGY
- Network meta-analysis of Chinese herbal injections combined with the chemotherapy for the treatment of pancreatic cancer
- (2017) Dan Zhang et al. MEDICINE
- Panax ginseng genome examination for ginsenoside biosynthesis
- (2017) Jiang Xu et al. GigaScience
- Chemotherapy remains an essential element of personalized care for persons with lung cancers
- (2016) M. D. Hellmann et al. ANNALS OF ONCOLOGY
- Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trial
- (2016) Yi Jiang et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
- (2016) Qi-Sen Guo et al. OncoTargets and Therapy
- Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis
- (2015) LIN YE et al. Oncology Letters
- PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment
- (2015) Wing Lam et al. Scientific Reports
- Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways
- (2014) Zhizheng Zhao et al. CANCER LETTERS
- Application of Response Evaluation Criteria of Traditional Chinese Medicine for Solid Tumor in advanced non-small cell lung cancer
- (2014) Nuan-zhu Xue et al. Chinese Journal of Integrative Medicine
- Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2014) Jean-Louis Pujol et al. Clinical Lung Cancer
- Huangqi−Honghua combination and its main components ameliorate cerebral infarction with Qi deficiency and blood stasis syndrome by antioxidant action in rats
- (2014) Jinyi Cao et al. JOURNAL OF ETHNOPHARMACOLOGY
- First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer
- (2013) Muhammad Wasif Saif et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Efficacy of Chinese Herbal Medicine as an Adjunctive Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
- (2013) Shi Guang Li et al. PLoS One
- Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway
- (2011) Weiru Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Shenqi fuzheng, an injection concocted from chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review
- (2010) Ju Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity
- (2010) W. Lam et al. Science Translational Medicine
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now